XUNFEIHEALTH (02506) surged more than 18% in Hong Kong trading, with shares rising 11.5% to HKD90.2 at press time, recording a turnover of HKD28.79 million.

The rally follows the company's recent announcement of winning a RMB428 million software services contract for China's National AI Application Pilot Base (focused on primary healthcare services). The project involves developing multiple 100-billion-parameter medical vertical large models, constructing a healthcare data resource platform, and creating replicable demonstration applications nationwide, with service commitments extending through 2028.

The project marks a significant evolution in XUNFEIHEALTH's business model, shifting from traditional one-time software delivery to an integrated "large model + data + operations" service approach. Notably, the contract emphasizes establishing a "long-term operational mechanism," addressing chronic industry challenges such as limited monetization avenues in medical AI. The company's project execution capabilities and historical operational data demonstrate its transition into a leader in AI medical infrastructure.